Record ID | harvard_bibliographic_metadata/ab.bib.10.20150123.full.mrc:99494654:2467 |
Source | harvard_bibliographic_metadata |
Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.10.20150123.full.mrc:99494654:2467?format=raw |
LEADER: 02467nam a2200445 a 4500
001 010148022-9
005 20061128124550.0
008 050504s2006 enka b 001 0 eng
010 $a 2005012980
015 $aGBA616392$2bnb
016 7 $a101247345$2DNLM
016 7 $a013385935$2Uk
020 $a9780195155648 (alk. paper)
020 $a0195155645 (alk. paper)
035 0 $aocm60348893
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dBAKER$dUKM$dDLC
042 $apcc
050 00 $aRC694.3$b.B39 2006
060 00 $a2006 F-938
060 10 $aQZ 170$bB396f 2006
082 00 $a616.1/3506$222
100 1 $aBecker, Richard C.
245 10 $aFibrinolytic and antithrombotic therapy :$btheory, practice, and management /$cRichard C. Becker, Frederick A. Spencer.
250 $a2nd ed.
260 $aOxford ;$aNew York :$bOxford University Press,$c2006.
300 $ax, 410 p. :$bill. ;$c21 cm.
504 $aIncludes bibliographical references and index.
505 0 $aHistorical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists -- Combination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke.
505 8 $aValvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies -- Venous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents.
650 0 $aThrombolytic therapy.
650 0 $aFibrinolytic agents.
650 0 $aThrombosis$xTreatment.
650 12 $aThrombolytic Therapy$xmethods.
650 22 $aBlood Coagulation Disorders$xdrug therapy.
650 22 $aBlood Coagulation Disorders$xphysiopathology.
650 22 $aCardiovascular Diseases$xdrug therapy.
650 22 $aFibrinolytic Agents$xtherapeutic use.
700 1 $aSpencer, Fredrick A.,$cMD.
988 $a20060803
906 $0OCLC